North American Patient Monitoring systems is valued as a 7.4 billion USD market in 2013 and is expected to become a $9.8 billion market by the end of 2018 and is expected to grow at a CAGR of 5.78%.
The market is basically segmented into different categories namely on the basis of the target parameter, the device used and on the basis of geography. The target parameter sector can be segmented into categories like Cardiac, Hemodynamic, Respiratory, Blood Glucose monitoring, Neurological and Child birth monitoring. The device sector can be divided into categories such as Care ports, Monitors, Networking and Wireless Parameters.
The geographical analysis and forecasting is available for the following regions:
The largest market share in the world is occupied by North America. The primary growth driver for North America is the rapid aging population and the increase in the chronic disease population at a good speed. Followed by North America is Europe which holds the second largest markets share, but the future growth is expected to be minimum. APAC is the region to look out for in the near future. This is due to the improved economic conditions which are driving the market.
The major drivers for this market growth are lack of skilled healthcare professionals, increase in the chronic disease population and the need to contain hospital expenses.
The major limitations are lack of reimbursement, regulatory framework issues and resistance to use IT by healthcare professionals.
The major players in this market are Abbott Labs, Alere Inc, Baxter, Bosch Medical, Boston Scientific, CR Bard, Cardiogram, Carematix, GE Healthcare, Intel, HoneyWell Med, Johnson & Johnson, Life Watch.
1.1 Report Description
1.2 Research Methodology
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
3. MARKET OVERVIEW
3.1 Market Defenition
3.1.2 Patient Monitoring Systems
3.2 Market Drivers
3.2.1 Lack of skilled healthcare professionals
3.2.2 Increased incidence of chronic diseases
3.2.3 Increase in ageing population
3.2.4 Need to contain hospital expenses
3.3 Market Barriers
3.3.1 Lack of reimbursement
3.3.2 Regulatory issues
3.3.3 Remote monitoring System
3.3.4 Resistance to IT from Healthcare professionals
4. NORTH AMERICA MARKETS : SEGMENTATION BY TARGET PARAMETER
4.1 Cardiac Monitoring
4.2 Heamodynamic Monitoring
4.3 Respiratory Monitoring
4.4 Neurological Monitoring
4.5 Blood Glucose Monitoring
4.6 Childbirth Monitoring
4.7 Body Temperature Monitoring
4.8 Remote monitoring System
5. NORTH AMERICA MARKETS : SEGMENTATION BY DEVICE
5.1 Care Ports
5.4 Wireless Networks
6. NORTH AMERICAN MARKETS: SEGMENTATION BY GEOGRAPHY
6.1 North America
7. Competitive Landscape
7.2 Mergers & Acquisitions
7.4 New Product Launch
8. COMPANY PROFILES
AMD NORTH AMERICA Telemedicine
Johnson & Johnson